The estimated Net Worth of Linda M Dairiki Shortliffe is at least $6.06 Tausend dollars as of 14 August 2012. Linda Shortliffe owns over 18,000 units of VIVUS stock worth over $6,065 and over the last 21 years Linda sold VVUS stock worth over $0.
Linda has made over 3 trades of the VIVUS stock since 2012, according to the Form 4 filled with the SEC. Most recently Linda exercised 18,000 units of VVUS stock worth $82,800 on 14 August 2012.
The largest trade Linda's ever made was exercising 52,000 units of VIVUS stock on 8 March 2012 worth over $227,240. On average, Linda trades about 4,423 units every 6 days since 2004. As of 14 August 2012 Linda still owns at least 13,000 units of VIVUS stock.
You can see the complete history of Linda Shortliffe stock trades at the bottom of the page.
Linda's mailing address filed with the SEC is 625 HALE ST, , PALO ALTO, CA, 94301-2211.
Over the last 21 years, insiders at VIVUS have traded over $6,261,269 worth of VIVUS stock and bought 5,180,746 units worth $13,074,554 . The most active insiders traders include Tide Capital, Llc North Tid..., Alexander J Denner und Ernest Mario. On average, VIVUS executives and independent directors trade stock every 39 days with the average trade being worth of $35,394. The most recent stock trade was executed by John P. Amos on 1 March 2019, trading 11,000 units of VVUS stock currently worth $53,350.
VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.
VIVUS executives and other stock owners filed with the SEC include: